This content is machine translated Pilot project in Switzerland OnlineDoctor offers digital prescriptions with electronic signature by dermatologist Especially when skin problems occur acutely, long waiting times for an appointment at a dermatological practice are a problem for many sufferers. OnlineDoctor – the leading provider of teledermatology in…
View Post 9 min This content is machine translated Interview with Prof. Dr. med. Gerd Burmester “With the JAK inhibitors, we can get much more out of them for our patients” Oral Janus kinase inhibitors (JAKi) have been expanding the treatment landscape for inflammatory rheumatoid diseases for several years. In the following interview, Prof. Dr. med. Gerd Burmester explains what this…
View Post 11 min This content is machine translated Interview on World Rheumatism Day “When those affected forget about the disease in their daily lives, it’s a particularly nice moment for us physicians.” Every year on October 12 is World Rheumatism Day. This was launched in 1996 by the international federation of self-help associations of rheumatism sufferers, “Arthritis and Rheumatism International (ARI)”. When…
View Post 1 min This content is machine translated Relapsed/refractory chronic lymphocytic leukemia The treatment of R/R CLL: guidelines, studies and case reports. The development of new, targeted substances can replace classic chemotherapies with more tolerable approaches 1 . In this webcast, Marc Heizmann, MD, Senior Physician Hematology and Transfusion Medicine at the Cantonal…
View Post 3 min This content is machine translated Transfusion Technology Blood grouping to the point Transfusion diagnostics are critical to survival. Without assured compatibility and tolerance, no blood donation would save lives. But trend forecasts fear increasing consumption with a simultaneous reduction in potential blood…
View Post 3 min This content is machine translated Conference on Retroviruses and Opportunistic Infections (CROI 2022) Five-year data of single-tablet regimen B/F/TAF published. At the 29th CROI, Gilead Sciences presented five-year data from two Phase 3 studies (Study 1489 and Study 1490) that evaluated use in untreated individuals living with HIV. The results…
View Post 6 min This content is machine translated Management of rheumatoid arthritis “Anyone diagnosed with RA today wants to be completely symptom-free.” With the development of conventional, biologic, and targeted disease-modifying antirheumatic drugs, the prognosis for rheumatoid arthritis has improved significantly since the 1990s. However, many patients still do not respond to…
View Post 6 min This content is machine translated Valérie Krafft, Executive Director of the Rheumatism League Switzerland: “Rheumatic diseases still meet with a lot of misunderstanding from the public” The Swiss Rheumatism League has been working for people with rheumatism since 1958. In an interview, Executive Director Valérie Krafft explains how the non-profit organization supports those affected, why the…
View Post 5 min This content is machine translated Virtual workshops for women with breast cancer “Sometimes it just takes the right start to make a positive change.” Breast cancer patients often face stress, anxiety and physical discomfort. The “I do it for me!” workshops are designed to enable those affected to meet these challenges. Dr. Sonja Ebner…
View Post 5 min This content is machine translated Focal spasticities “An enormous relief in daily practice”. Botulinum toxins are increasingly used in the treatment of spasticity, but so far different preparations have been used depending on the etiology and localization [1]. A new preparation can now…
View Post 5 min This content is machine translated Interview with Prof. Dr. med. Pascal Richette Facing the challenges of psoriatic arthritis management Despite remarkable progress in the treatment of patients with psoriatic arthritis (PsA), the management of this chronic disease still poses major challenges [1]. In the following interview, Prof. Pascal Richette,…
